Role of the IL-33/ST2L axis in colorectal cancer progression
Authors:
- 1 September 2019
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 343, 103740
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (25430110, 16K10594)
- Ministry of Education, Culture, Sports, Science and Technology (23112510)
- Shimane University
This publication has 132 references indexed in Scilit:
- The Role of IL-33 in Gut Mucosal InflammationMediators of Inflammation, 2013
- IL-33 induces innate lymphoid cell–mediated airway inflammation by activating mammalian target of rapamycinJournal of Allergy and Clinical Immunology, 2012
- The Immune-Modulating Cytokine and Endogenous Alarmin Interleukin-33 Is Upregulated in Skin Exposed to Inflammatory UVB RadiationThe American Journal of Pathology, 2011
- Nuocytes represent a new innate effector leukocyte that mediates type-2 immunityNature, 2010
- Immunity, Inflammation, and CancerCell, 2010
- IL-33–activated dendritic cells induce an atypical TH2-type responseJournal of Allergy and Clinical Immunology, 2009
- Cancer-related inflammationNature, 2008
- A novel IL-1 family cytokine, IL-33, potently activates human eosinophilsJournal of Allergy and Clinical Immunology, 2008
- Mast cells are an essential hematopoietic component for polyp developmentProceedings of the National Academy of Sciences, 2007
- IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factorin vivoProceedings of the National Academy of Sciences, 2007